8-Bromo-7-fluoro-1-isopropyl-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one

Catalog No.: 
ACRCTB237
CAS No.: 
2089288-27-5
Molecular Formula: 
C14H13BrFN3O
Molecular Weight: 
338.18
8-Bromo-7-fluoro-1-isopropyl-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$738.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name8-Bromo-7-fluoro-1-isopropyl-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one
IUPAC Name8-bromo-7-fluoro-1-isopropyl-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one
MDL No.MFCD32269290
Molecular FormulaC14H13BrFN3O
Molecular Weight338.18
SMILESO=C1N(C)C2=CN=C3C=C(C(Br)=CC3=C2N1C(C)C)F
InChI KeyNKDMNFNFCCPJBQ-UHFFFAOYSA-N
Synonym2H-Imidazo[4,5-c]quinolin-2-one, 8-bromo-7-fluoro-1,3-dihydro-3-methyl-1-(1-methylethyl)-;8-bromo-7-fluoro-1-isopropyl-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one
CAS No.2089288-27-5

Synthetic Route by SureRoute

1. ACRCTB237 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRCTB237 route product structure diagram
    ACRCTB2372089288-27-5
Inquiry

2. ACRCTB237 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRCTB237 route product structure diagram
    ACRCTB2372089288-27-5
Inquiry

3. ACRCTB237 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRCTB237 route product structure diagram
    ACRCTB2372089288-27-5
Inquiry

Comments (0)